O
OrbiMed
Private Equity · Founded 1989 · New York City, United States
OrbiMed’s biggest holdings
Dealroom has OrbiMed’s ownership percentage in only 1 company, too few to size its stakes.
Request ownership dataOrbiMed’s biggest exits
Portfolio companies that IPO’d or were acquired at $1B+, with the valuation recorded at exit and — for those still public — their value today. Exit events come from each company’s funding-round history; entry stage from OrbiMed’s transaction record.
OrbiMed’s portfolio companies
The 60 highest-funded portfolio companies, of 393 tracked.
Ph
Ca
Tr
Mi
Za
Be
I-
Od
Xt
Av
Mi
Ab
Ce
AC
Gu
In
Di
Ol
In
Ar
Cr
Sp
Ga
Sc
Ra
Co
Ve
Ad
Up
Ar
Cu
Ac
Ca
An
Al
Wi
Te
Ty
Pi
Re
As
Er
Sh
Ca
Cl
De
Ad
Ik
AD
Ha
Re
So
St
Ar
Ge
Ha
Ha
Na
Ia
AmWhere OrbiMed’s portfolio founders come from
139 founders across the 100 highest-funded portfolio companies — by current location, university attended, and the companies they worked at before founding. Sourced from the founder records the API links to each portfolio company.
-
United States93
-
China12
-
Denmark6
-
Canada4
-
Israel4
-
Australia3
-
India3
-
Netherlands3
-
United Kingdom3
-
Germany2
-
Harvard University11
-
Massachusetts Institute of Technology8
-
Stanford University5
-
University of California, Berkeley4
-
Wharton School of the University of Pennsylvania4
-
Columbia University3
-
Harvard Medical School3
-
University of Copenhagen3
-
University of Texas at Austin3
-
University of Virginia3
-
Novartis6
-
Alantos Pharmaceuticals5
-
Genentech5
-
Massachusetts Institute of Technology5
-
McKinsey & Company5
-
Sanofi Aventis5
-
Harvard Medical School3
-
Lucentis3
-
MIT-IBM Watson AI Lab3
-
Aiolos Bio2
OrbiMed in the New York City ecosystem
The OrbiMed office with the hot startups, most funded companies and other investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →









